Page 16 - Johnson Medtech News Today

Johnson & Johnson MedTech executive vice president and worldwide chair is stepping down, the company said Oct. 23.

Johnson & Johnson announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position...

Johnson & Johnson MedTech is restructuring its DePuy Synthes orthopedic business, executives said today on a quarterly earnings call with investors. J&J…

Johnson & Johnson today posted third-quarter results that beat the overall consensus on Wall Street.

The warning letter is the latest indication of the fresh scrutiny the FDA is paying to software tools and decision aids.

Johnson & Johnson MedTech is restructuring its DePuy Synthes orthopedic unit, executives said on a quarterly earnings call with investors.

At DeviceTalks West this week, we’ll explore the design, economics and broader opportunities for surgical robotics.

COVID-19 health care costs are significantly greater than those for influenza and pneumonia. Treatment costs for severe COVID-19 exceed those for influenza and pneumonia by approximately $50,000.

The FDA wrote Abiomed up for its response to problems with the heart pump and for selling its Impella Connect System without approval.

For all the talk around what digital can accomplish in medtech, questions remain, experts said today at AdvaMed's The MedTech Conference.